Amarin Corp Plc (AMRN)

[IgnoranceIsBliss]

I do think the FDA is experiencing behind the scenes pressure — and the BPs provide FDA seniors with the next step in their careers — the one where they monetize their access.

I personally think the pressure isn’t to shut this down, but it could be to limit the label. My fear is secondary only, and there are spurious but make-able arguments for that.

The medical community, as represented by the panel members and the horde of “amicus” commenters, needs to bury this bad inclination to “err on the side of caution”... which is really just appeasing the big players with the sexy jobs. There is nothing responsible about limiting access to a cheap miracle drug.